These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3561846)

  • 21. [Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
    Gaskina TK; Dolgov AV; Kurilovich SA
    Vopr Med Khim; 1987; 33(4):96-9. PubMed ID: 3660750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
    Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of SeHCAT retention as an indicator of terminal ileal involvement in inflammatory bowel disease.
    Holdstock G; Phillips G; Hames TK; Condon BR; Fleming JS; Smith CL; Ackery DM
    Eur J Nucl Med; 1985; 10(11-12):528-30. PubMed ID: 4029210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
    Andreuzzi B; Vai C; Santese R; Andreuzzi P; Cantoni L
    Minerva Med; 1984 Mar; 75(13):749-56. PubMed ID: 6717831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of hepatic vitamin E status in adult patients with liver disease.
    Nagita A; Ando M
    Hepatology; 1997 Aug; 26(2):392-7. PubMed ID: 9252150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis.
    Potter BJ; Elias E; Thomas HC; Sherlock S
    Gastroenterology; 1980 May; 78(5 Pt 1):1034-40. PubMed ID: 7380176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.
    Haustein KO; Schenker E
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):190-6. PubMed ID: 3922902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorbed dose to man from the Se-75 labeled conjugated bile salt SeHCAT: concise communication.
    Soundy RG; Simpson JD; Ross HM; Merrick MV
    J Nucl Med; 1982 Feb; 23(2):157-61. PubMed ID: 6799623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases.
    Czuczejko J; Zachara BA; Staubach-Topczewska E; Halota W; Kedziora J
    Acta Biochim Pol; 2003; 50(4):1147-54. PubMed ID: 14740001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SeHCAT absorption: a simple test of ileal dysfunction.
    Fagan EA; Chadwick VS; Baird IM
    Digestion; 1983; 26(3):159-65. PubMed ID: 6406283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carnitine metabolism in patients with chronic liver disease.
    Krähenbühl S; Reichen J
    Hepatology; 1997 Jan; 25(1):148-53. PubMed ID: 8985281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Polyunsaturated phosphatidylcholine + vitamin B complex in the therapy of alcoholic hepatopathies. A controlled study versus standard therapy].
    Hazuka V; Roubal R
    Clin Ter; 1987 Dec; 123(5):369-75. PubMed ID: 2972496
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of the isotope method for studying albumin metabolism in patients with chronic liver diseases].
    Vinogradov VA; Baranenkov AI
    Ter Arkh; 1974; 46(3):118-23. PubMed ID: 4828489
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bile acids in chronic hepatopathies].
    Luciani A; Massari M; Montanari P; Nora A; Zandomeneghi R
    Minerva Med; 1986 Dec; 77(49-50):2287-92. PubMed ID: 3808385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometry DNA content and morphobiological characteristics in chronic and neoplastic human liver disease.
    Paradiso A; Barletta A; Prete F; Pellecchia A; Romagno D; Lucchese G; Benvestito V; Zito FA; Russo S; De Lena M
    Ital J Gastroenterol; 1995; 27(1):8-12. PubMed ID: 7795288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic results with Hepsan in selected forms of hepatitis].
    Schneider-Reinkens A
    MMW Munch Med Wochenschr; 1977 Jun; 119(25):869-70. PubMed ID: 408608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.